Comparing outcomes after off-pump coronary artery bypass versus drug-eluting stent in diabetic patients

Journal of Cardiology

Volumn 59, Issue 2, 2012, Pages 195-201

  Dohi, Shizuyuki ^a   Kajimoto, Kan ^a   Miyauchi, Katsumi ^a   Yamamoto, Taira ^a   Tambara, Keiichi ^a   Inaba, Hirotaka ^a   Kuwaki, Kenji ^a   Tamura, Hiroshi ^a   Kojima, Takahiko ^a   Yokoyama, Ken ^a   Kurata, Takeshi ^a   Daida, Hiroyuki ^a   Amano, Atsushi ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Diabetes mellitus; Interventional cardiology

Indexed keywords

RAPAMYCIN;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CAROTID ARTERY STENTING; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; REVASCULARIZATION; RISK FACTOR; STROKE; SURVIVAL; VASCULAR DISEASE;

AGED; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY DISEASE; DIABETES COMPLICATIONS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; SIROLIMUS; TREATMENT OUTCOME;

EID: 84862823478     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.10.004     Document Type: Article

References (20)

1. Stamler J., Vaccaro O., Neaton J.D., Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444.
2. Hlatky M.A., Boothroyd D.B., Bravata D.M., Boersma E., Booth J., Brooks M.M., Carrié D., Clayton T.C., Danchin N., Flather M., Hamm C.W., Hueb W.A., Kähler J., Kelsey S.F., King S.B., et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009, 373:1190-1197.
3. SoS Investigators Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002, 360:965-970.
4. Hueb W., Soares P.R., Gersh B.J., César L.A., Luz P.L., Puig L.B., Martinez E.M., Oliveira S.A., Ramires J.A. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 2004, 43:1743-1751.
5. Hannan E.L., Racz M.J., Walford G., Jones R.H., Ryan T.J., Bennett E., Culliford A.T., Isom O.W., Gold J.P., Rose E.A. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005, 352:2174-2183.
6. Javaid A., Steinberg D.H., Buch A.N., Corso P.J., Boyce S.W., Pinto Slottow T.L., Roy P.K., Hill P., Okabe T., Torguson R., Smith K.A., Xue Z., Gevorkian N., Suddath W.O., Kent K.M., et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007, 116:200-206.
7. Caixeta A., Leon M.B., Lansky A.J., Nikolsky E., Aoki J., Moses J.W., Schofer J., Morice M.C., Schampaert E., Kirtane A.J., Popma J.J., Parise H., Fahy M., Mehran R. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009, 54:894-902.
8. Rubartelli P., Petronio A.S., Guiducci V., Sganzerla P., Bolognese L., Galli M., Sheiban I., Chirillo F., Ramondo A., Bellotti S. Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial. Eur Heart J 2010, 31:2014-2020. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche II GISE Investigators.
9. Babapulle M.N., Joseph L., Bélisle P., Brophy J.M., Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004, 364:583-591.
10. Emmert M.Y., Salzberg S.P., Seifert B., Rodriguez H., Plass A., Hoerstrup S.P., Grünenfelder J., Falk V. Is off-pump superior to conventional coronary artery bypass grafting in diabetic patients with multivessel disease?. Eur J Cardiothorac Surg 2011, 40:233-239.
11. Puskas J.D., Williams W.H., Duke P.G., Staples J.R., Glas K.E., Marshall J.J., Leimbach M., Huber P., Garas S., Sammons B.H., McCall S.A., Petersen R.J., Bailey D.E., Chu H., Mahoney E.M., et al. Off-pump coronary artery bypass grafting provides complete revascularization with reduced myocardial injury, transfusion requirements, and length of stay: a prospective randomized comparison of two hundred unselected patients undergoing off-pump versus conventional coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003, 125:797-808.
12. Serruys P.W., Morice M.C., Kappetein A.P., Colombo A., Holmes D.R., Mack M.J., Ståhle E., Feldman T.E., van den Brand M., Bass E.J., Van Dyck N., Leadley K., Dawkins K.D., Mohr F.W. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972. SYNTAX Investigators.
13. Briguori C., Condorelli G., Airoldi F., Focaccio A., D'Andrea D., Cannavale M., Abarghouei A.A., Giordano S., De Vivo F., Ricciardelli B., Colombo A. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 2007, 99:779-784.
14. Yamagata K., Kataoka Y., Kokubu N., Kasahara Y., Abe M., Nakajima H., Kobayashi J., Otsuka Y. A 3-year clinical outcome after percutaneous coronary intervention using sirolimus-eluting stent and off-pump coronary artery bypass grafting for the treatment of diabetic patients with multivessel disease. Circ J 2010, 74:671-678.
15. Hannan E.L., Wu C., Walford G., Culliford A.T., Gold J.P., Smith C.R., Higgins R.S., Carlson R.E., Jones R.H. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008, 358:331-341.
16. Morice M.C., Serruys P.W., Kappetein A.P., Feldman T.E., Ståhle E., Colombo A., Mack M.J., Holmes D.R., Torracca L., van Es G.A., Leadley K., Dawkins K.D., Mohr F. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010, 121:2645-2653.
17. Chu D., Bakaeen F.G., Dao T.K., LeMaire S.A., Coselli J.S., Huh J. On-pump versus off-pump coronary artery bypass grafting in a cohort of 63,000 patients. Ann Thorac Surg 2009, 87:1820-1826.
18. Hirose H., Noguchi C., Inaba H., Tambara K., Yamamoto T., Yamasaki M., Kikuchi K., Amano A. The role of EuroSCORE in patients undergoing off-pump coronary artery bypass. Interact Cardiovasc Thorac Surg 2010, 10:771-776.
19. Tsuruta R., Miyauchi K., Yamamoto T., Dohi S., Tambara K., Dohi T., Inaba H., Kuwaki K., Daida H., Amano A. Effect of preoperative hemoglobin A1c levels on long-term outcomes for diabetic patients after off-pump coronary artery bypass grafting. J Cardiol 2011, 57:181-186.
20. Yamagishi S. Cardiovascular disease in recent onset diabetes mellitus. J Cardiol 2011, 57:257-262.